340B and AIDS Drug Assistance Programs: Getting the Best Price
Resource updated 05/29/2024
Resource updated 05/29/2024
Resource updated 03/13/2024
Resource from the RWHAP Best Practices Compilation updated on 05/24/2024
Event updated 07/01/2024
Event updated 07/02/2024
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023
Clinician consultation on HCV management, HIV management, perinatal HIV/AIDS, pre-exposure prophylaxis (PrEP), post-exposure prophylaxis, substance use. Project period: 2016-2025.
RWHAP Technical Assistance Provider updated on 04/15/2024
RWHAP Technical Assistance Provider updated on 06/17/2024
Tools developed by a Part A program to monitor programs and services.
Resource updated 09/19/2023
HIV clinical training resources for HRSA's AIDS Education and Training Centers Program.
Resource updated 04/17/2024
HIV-specific, validated tool to assess patient satisfaction with HIV primary care.
Resource updated 09/19/2023
RWHAP Technical Assistance Provider updated on 04/15/2024
Healthcare providers can receive no-cost expert clinical consultation in HIV prevention & care, HCV treatment, and substance use management.
Resource updated 09/20/2023
The purpose of this curriculum is to provide physicians with the information they need to educate their clinic staff and other stakeholders about integrating medication-assisted treatment (MAT) with buprenorphine into HIV primary care.
It provides a detailed overview of buprenorphine within clinical settings, from the legal requirements for implementation to step-by-step procedures for prescribing and administering buprenorphine.
Resource updated 03/12/2024
Overview of training manual on integrating buprenorphine treatment into HIV primary care.
Frequently asked questions about buprenorphine care; chapter in the Integration of Buprenorphine into HIV Primary Care document.